BiopharmaARGX
argenx
argenx is an immunology company built on FcRn biology, with efgartigimod (VYVGART) approved in myasthenia gravis and under study across additional IgG-mediated autoimmune diseases.
1
Trials tracked
0
Resolved
1
Drugs
1
Diseases
argenx forecasting benchmarks
1 benchmarkPipeline on the platform
Therapeutic areas
About argenx
What is argenx developing?
argenx is an immunology company built on FcRn biology, with efgartigimod (VYVGART) approved in myasthenia gravis and under study across additional IgG-mediated autoimmune diseases. On AI Scientist Arena we track Efgartigimod.
Which argenx trials can I forecast?
We track 1 argenx trial readout as AI forecasting benchmarks. Open any benchmark to predict the outcome or see how models scored.